• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Cardiac Enzyme Elevation (1838); Gastrointestinal Hemorrhage (4476)
Event Date 07/31/2019
Event Type  Injury  
Event Description
It was alleged that while using coaguchek xs meter serial number (b)(6), a patient who is on anticoagulation to reduce the risk of clot formation due to antiphospholipid antibody syndrome had in late (b)(6) 2019 significant gastrointestinal bleeding which required hospitalization and transfusion.Reportedly, the patient was also treated for a non-st elevation myocardial infarction following this incident.At the hospital, on approximately (b)(6) 2019 it was reported that the patient had a laboratory draw with an inr in the 7 range and a low hemoglobin.Reportedly, this delayed a planned angiogram.Reportedly, the patient was hospitalized for approximately 5 days and received 2 units of blood.It was reported that previous to the event his coaguchek device indicated a subtherapeutic inr, (b)(6) 2019 1.4 inr, (b)(6) 2019 1.3 inr, (b)(6) 2019 2.3 inr.The patient¿s therapeutic range was reported to be 3.0-4.0 inr.It is reported that he increased his warfarin an unknown amount any time the inr was below 3.0 inr.Reportedly the patient¿s regular testing interval is weekly when the inr is stable.This mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
Section e3: occupation is patient/consumer.The reporter's meter was provided for investigation where it was tested using retention test strips and retention controls.Testing results (qc range = 2.3 - 3.5 inr): qc 1: 2.8 inr, qc 2: 2.8 inr, qc 3: 2.9 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling: "the presence of anti-phospholipid antibodies (apas) such as lupus antibodies (la) may lead to prolonged clotting times, i.E., they may cause false-high inr values.If you have or suspect that you have apas, discontinue testing until you discuss with your physician.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17513450
MDR Text Key320916689
Report Number1823260-2023-02598
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 08/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot NumberASKU
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/25/2023
Initial Date Manufacturer Received 07/13/2023
Initial Date FDA Received08/11/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
METFORMIN.; TOUJEO INSULIN.; TRULICITY.; WARFARIN.
Patient Outcome(s) Hospitalization; Other;
Patient Age57 YR
Patient SexMale
Patient Weight136 KG
-
-